PRCH Physician Helps Convince FDA to Approve New EC
June 17, 2010
After a hearing today, the FDA's Advisory Committee for Reproductive Health Drugs voted unanimously to recommend quick FDA approval for ulipristal acetate, a new form of emergency contraception. Leadership Training Academy alum Sara Imershein, MD, testified before the committee: "We know that more emergency contraception options will improve our care for women." Read Dr. Imershein's complete testimony.
Who We Are
PRCH is a doctor-led national advocacy organization. We use evidence-based medicine to promote sound
reproductive health policies. We believe
in reproductive choice for everyone.
Stand up for abortion providers and patients! Add your name to our Abortion Provider's Declaration of Rights.
Stay Informed
Most Popular
Choice Words
“I provide abortions because I value the life and health of my patients, and because when abortion is not legal, safe, and accessible, women suffer and die.”